Ligand validation:3NYF

HHI: (2Z)-3-(1H-imidazol-5-yl)-2-iminopropanoic acid

HHI is a Ligand Of Interest in 3NYF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NYF_HHI_A_1600	44%	20%	0.188	0.917	1.73	1.8	1	1	1	0	100%	0.4636

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.